MRK
Merck & Co Inc
Pharmaceuticals
Merck & Co Inc (MRK) Financials
Annual revenue, profit, EPS and free cash flow for MRK, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $65.0B | — | — | — | $7.28 | $12.4B |
| FY2024 | $64.2B | — | — | — | $6.74 | $18.1B |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.